Description

Blood pressure measurements at baseline and endpoint across the curcumin, coenzyme Q10, combination, and placebo groups, assessing the antihypertensive potential of supplementation in metabolic syndrome.

Figure 4

Chart

Source Paper

Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial.

Nutrition journal (2022)

PMID: 36192751

DOI: 10.1186/s12937-022-00816-7

Cite This Figure

![Figure 4: Blood pressure measurements at baseline and endpoint across the curcumin, coenzyme Q10, combination, and placebo groups, assessing the antihypertensive potential of supplementation in metabolic syndrome.]()

> Source: Abbas Ali Sangouni et al. "Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in ." *Nutrition journal*, 2022. PMID: [36192751](https://pubmed.ncbi.nlm.nih.gov/36192751/)

<figure>
  <img src="" alt="Blood pressure measurements at baseline and endpoint across the curcumin, coenzyme Q10, combination, and placebo groups, assessing the antihypertensive potential of supplementation in metabolic syndrome." />
  <figcaption>Figure 4. Blood pressure measurements at baseline and endpoint across the curcumin, coenzyme Q10, combination, and placebo groups, assessing the antihypertensive potential of supplementation in metabolic syndrome.<br>  Source: Abbas Ali Sangouni et al. "Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in ." <em>Nutrition journal</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36192751/">36192751</a></figcaption>
</figure>

Related Evidence

Coenzyme Q10 (CoQ10) for High Blood Pressure (Hypertension)

Grade B · 12 studies

Curcumin for High Cholesterol (Hyperlipidemia)

Grade C · 7 studies